Pretomanid resistance: An update on emergence, mechanisms and relevance for clinical practice-Reference-Cited by-同舟云学术

Pretomanid resistance: An update on emergence, mechanisms and relevance for clinical practice

Published:2023-10 Issue:4 Volume:62 Page:106953
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Nguyen Thi Van Anh^ORCID,Nguyen Quang Huy^ORCID,Nguyen Tran Nam Tien^ORCID,Anthony Richard M.,Vu Dinh Hoa^ORCID,Alffenaar Jan-Willem C.^ORCID

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference61 articles.

1. Bedaquiline resistance: its emergence, mechanism, and prevention;Nguyen;Clin Infect Dis,2018

2. Delamanid resistance: update and clinical management;Nguyen;Clin Infect Dis,2020

3. Global tuberculosis report 2019,2019

4. Meeting report of the WHO expert consultation on the definition of extensively drug-resistant tuberculosis,2020

5. TB Alliance and Mylan announce global collaboration to commercialize investigational drug pretomanid as part of two regimens to treat tuberculosis (TB),2019

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transmission is a key driver of extensively drug-resistant tuberculosis;2024-06-30

2. Fluorine in the pharmaceutical industry: Synthetic approaches and application of clinically approved fluorine-enriched anti-infectious medications;European Journal of Medicinal Chemistry;2024-05

3. Clinical research progress of novel antituberculosis drugs on multidrug-resistant tuberculosis;Postgraduate Medical Journal;2024-01-10